These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 8051395

  • 1. The acute and chronic effects of isosorbide-5-mononitrate on portal haemodynamics in cirrhosis.
    Grose RD, Plevris JN, Redhead DN, Bouchier IA, Hayes PC.
    J Hepatol; 1994 Apr; 20(4):542-7. PubMed ID: 8051395
    [Abstract] [Full Text] [Related]

  • 2. Effects of isosorbide-5-mononitrate on variceal pressure and systemic and splanchnic haemodynamics in patients with cirrhosis.
    Escorsell A, Feu F, Bordas JM, García-Pagán JC, Luca A, Bosch J, Rodés J.
    J Hepatol; 1996 Apr; 24(4):423-9. PubMed ID: 8738728
    [Abstract] [Full Text] [Related]

  • 3. Long-term haemodynamic effects of isosorbide 5-mononitrate in patients with cirrhosis and portal hypertension.
    García-Pagán JC, Feu F, Navasa M, Bru C, Ruiz del Arbol L, Bosch J, Rodés J.
    J Hepatol; 1990 Sep; 11(2):189-95. PubMed ID: 2123914
    [Abstract] [Full Text] [Related]

  • 4. Portal and systemic haemodynamic response to acute and chronic administration of low and high dose isosorbide-5-mononitrate in patients with cirrhosis.
    Jones AL, Bangash IH, Walker J, Simpson KJ, Finlayson ND, Hayes PC.
    Gut; 1995 Jan; 36(1):104-9. PubMed ID: 7890211
    [Abstract] [Full Text] [Related]

  • 5. Reduction of portal pressure by isosorbide-5-mononitrate in patients with cirrhosis. Effects on splanchnic and systemic hemodynamics and liver function.
    Navasa M, Chesta J, Bosch J, Rodés J.
    Gastroenterology; 1989 Apr; 96(4):1110-8. PubMed ID: 2925055
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect and mechanism of action of isosorbide-5-mononitrate.
    Hayes PC, Westaby D, Williams R.
    Gut; 1988 Jun; 29(6):752-5. PubMed ID: 3384359
    [Abstract] [Full Text] [Related]

  • 11. Acute administration of carvedilol is more effective than propranolol plus isosorbide-5-mononitrate in the reduction of portal pressure in patients with viral cirrhosis.
    Lin HC, Yang YY, Hou MC, Huang YT, Lee FY, Lee SD.
    Am J Gastroenterol; 2004 Oct; 99(10):1953-8. PubMed ID: 15447755
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Systemic and regional hemodynamic effects of isosorbide dinitrate in patients with liver cirrhosis and portal hypertension.
    Mols P, Hallemans R, Melot C, Lejeune P, Naeije R.
    J Hepatol; 1989 May; 8(3):316-24. PubMed ID: 2732445
    [Abstract] [Full Text] [Related]

  • 14. [Propranolol and 5-isosorbide mononitrate in patients with cirrhosis: systemic and portal hemodynamic events].
    Castaño G, Viudez P, Sookoian S, Carlevaro O, Riccitelli M, Frider B.
    Gastroenterol Hepatol; 2000 May; 23(6):275-81. PubMed ID: 15324622
    [Abstract] [Full Text] [Related]

  • 15. Clinical vs haemodynamic response to drugs in portal hypertension.
    McCormick PA, Patch D, Greenslade L, Chin J, McIntyre N, Burroughs AK.
    J Hepatol; 1998 Jun; 28(6):1015-9. PubMed ID: 9672178
    [Abstract] [Full Text] [Related]

  • 16. Effects of isosorbide dinitrate on portal hypertension in alcoholic cirrhosis.
    Merkel C, Finucci G, Zuin R, Bazzerla G, Bolognesi M, Sacerdoti D, Gatta A.
    J Hepatol; 1987 Apr; 4(2):174-80. PubMed ID: 3584925
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.